Alkem Laboratories' Stock Sees Slight Dip, But Overall Trend Remains Positive
Alkem Laboratories, a leading pharmaceutical company in India, has recently faced a slight dip in its stock performance. On October 16, 2024, the company's stock saw a decline of -3.1%. However, this should not be a cause for concern for investors as the overall trend for Alkem Laboratories has been positive.
According to MarketsMOJO, a leading stock analysis platform, the stock call for Alkem Laboratories is 'Buy'. This is a positive sign for investors, indicating that the company has strong potential for growth in the future.
In terms of price performance, Alkem Laboratories has underperformed the sector by -2.35% on the day of October 16. However, it is important to note that this is a short-term trend and does not reflect the overall performance of the company.
The stock has also seen a slight dip after three consecutive days of gains, which could be seen as a trend reversal. However, this should not be a cause for concern as the company's stock is still performing well in the long run.
On the day of October 16, Alkem Laboratories' stock touched an intraday low of Rs 6056.95, which is a decline of -3.03%. This could be attributed to market fluctuations and should not be a cause for alarm for investors.
In terms of moving averages, Alkem Laboratories' stock is currently higher than its 50-day, 100-day, and 200-day moving averages. However, it is lower than its 5-day and 20-day moving averages. This indicates that the stock has been performing well in the long run, but has seen a slight dip in the short term.
Compared to the overall performance of the Sensex, Alkem Laboratories' stock has seen a decline of -3.17% on October 16, while the Sensex has seen a decline of -0.42%. In the past month, Alkem Laboratories' stock has seen a decline of -4.63%, while the Sensex has seen a decline of -1.82%. This shows that the company's stock is still performing well compared to the overall market.
In conclusion, while Alkem Laboratories' stock may have seen a slight dip on October 16, the overall trend for the company is positive. With a 'Buy' call from MarketsMOJO and strong long-term performance, Alkem Laboratories remains a promising investment in the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
{{text.big_txt}}
{{text .small_txt}}
{{dashverdictresult.dashboard.stock_details.short_name}}
SEND BY EMAIL
Register now to see if the stock’s characteristics match your investment style
Subscribe now to see if the stock's characteristics match your investment style
{{dashverdictresult.dashboard.risk_return_voltality.risk_type}}, {{dashverdictresult.dashboard.risk_return_voltality.return_type}}
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
Create your portfolio and know how much should this stock be in your portfolio
Subscribe now to know how much you should hold in this stock
We have found 2 better stocks that you can consider
{{dashverdictresult.dashboard.return_text}}
Investors Returns (3 years) –
| Period | 6M | 1Y | 2Y | 3Y |
| {{ keyd.val }} | ||||
| {{ keyd.val }} |
Quality: {{dashverdictresult.dashboard.dotsummary.q_txt}}
Valuation: {{dashverdictresult.dashboard.dotsummary.v_txt}}
Quarterly Financial Trend: {{dashverdictresult.dashboard.dotsummary.f_txt}}
Technicals: {{dashverdictresult.dashboard.dotsummary.tech_txt}}
Stock Info:
BSE – {{dashverdictresult.dashboard.stock_details.scripcode}}/ NSE – {{dashverdictresult.dashboard.stock_details.symbol}}
Market Cap – {{dashverdictresult.dashboard.priceinfo.mcap_class}} (Rs. {{dashverdictresult.dashboard.priceinfo.mcap| number :0}} cr)
Sector – {{dashverdictresult.dashboard.stock_details.ind_name}}
52 w H/L (Rs.) – {{dashverdictresult.dashboard.priceinfo.wk_high52}}/{{dashverdictresult.dashboard.priceinfo.wk_low52}}
Average vol (6M) – {{dashverdictresult.dashboard.priceinfo.vol}}
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
